關於這一集
Can you really just take out part of the bladder? It's one of the most common questions bladder cancer surgeons hear—and in this episode of Bladder Cancer Matters, host Rick Bangs sits down with renowned urologic oncologist Dr. John Gore to break it all down. From TURBTs to partial cystectomies, they explore when bladder-sparing approaches are appropriate, what the real risks and benefits are, and how treatment choices affect long-term outcomes. Whether you're a patient, caregiver, or advocate, this episode is packed with the kind of honest, expert insight that can help you make more informed decisions.
英語
美國
逐字稿 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
本 Podcast 中的其他單集
In this powerful episode of Bladder Cancer Matters, Rick Bangs sits down with Mike Vasallo, a high school assistant principal diagnosed with early-onset bladder cancer at 46 who turned fear and uncertainty into purpose.
Mike shares his raw, honest journey through diagnosis, treatment and recovery—…
In this episode of Bladder Cancer Matters, host Rick Bangs sits down with urologic oncologist Dr. Minhaj Siddiqui to break down a critical but often overlooked gap in bladder cancer care—and what it means for patients.
They explore how non-muscle-invasive bladder cancer is treated, why a simple st…
In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with ImmunityBio's Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment.
They unpack how next-generation immunotherapies like ANKTIVA—paired with innovativ…
In this powerful episode of Bladder Cancer Matters, a podcast by the Bladder Cancer Advocacy Network, host and survivor Rick Bangs sits down with Vanderbilt nurse Bree Duncan to explore a groundbreaking new role dedicated solely to supporting women with bladder cancer.
Created through the vision …
In this episode of Bladder Cancer Matters, host Rick Bangs speaks with Dr. Josefa Briceno of AstraZeneca about why bladder cancer care may be at a true turning point. From exploring immunotherapy earlier in the disease journey — even around the time of surgery — to strengthening collaboration betwe…
免責聲明: 本頁面嵌入的 Podcast 和封面圖片來自 Bladder Cancer Advocacy Network，歸其所有者所有，與 Listen Notes, Inc. 無關聯，也未獲得 Listen Notes, Inc. 背書。
